Syndax Pharmaceuticals Stock Price on March 13, 2024
| SNDX Stock | USD 14.94 0.62 3.98% |
Below is the normalized historical share price chart for Syndax Pharmaceuticals extending back to March 03, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Syndax Pharmaceuticals stands at 14.94, as last reported on the 12th of December 2024, with the highest price reaching 15.79 and the lowest price hitting 14.57 during the day.
If you're considering investing in Syndax Stock, it is important to understand the factors that can impact its price. Syndax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0697, which indicates the firm had a -0.0697% return per unit of risk over the last 3 months. Syndax Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Syndax Pharmaceuticals' Coefficient Of Variation of (1,677), risk adjusted performance of (0.03), and Variance of 17.65 to confirm the risk estimate we provide.
At this time, Syndax Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 643.5 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 38.8 M in 2024. . At this time, Syndax Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 2.88 in 2024, whereas Price To Sales Ratio is likely to drop 6.97 in 2024. Syndax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of March 2016 | 200 Day MA 20.468 | 50 Day MA 18.272 | Beta 0.917 |
Syndax |
Sharpe Ratio = -0.0697
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNDX |
Estimated Market Risk
| 4.21 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Syndax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Syndax Pharmaceuticals by adding Syndax Pharmaceuticals to a well-diversified portfolio.
Price Book 3.4802 | Enterprise Value Ebitda (105.26) | Price Sales 79.7027 | Shares Float 85 M | Wall Street Target Price 36.8462 |
Related Headline
Inozyme Pharma Headline on 13th of March 2024
Acquisition by Subramanian Sanjay of 165000 shares of Inozym... by Subramanian Sanjay
Filed transaction by Inozyme PharmaInc Officer: Svp, Cfo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Syndax Pharmaceuticals Valuation on March 13, 2024
It is possible to determine the worth of Syndax Pharmaceuticals on a given historical date. On March 13, 2024 Syndax was worth 23.68 at the beginning of the trading date compared to the closed value of 23.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Syndax Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Syndax Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Syndax Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Syndax Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 23.77 | 24.08 | 23.05 | 23.86 | 1,483,594 | |
03/13/2024 | 23.68 | 24.21 | 23.08 | 23.76 | 1,075,839 |
| 23.53 | 23.80 | 22.34 | 22.65 | 1,107,750 |
| Backtest Syndax Pharmaceuticals | | | Syndax Pharmaceuticals History | | | Syndax Pharmaceuticals Valuation | Previous | Next |
Syndax Pharmaceuticals Trading Date Momentum on March 13, 2024
| On March 14 2024 Syndax Pharmaceuticals was traded for 22.65 at the closing time. The top price for the day was 23.80 and the lowest listed price was 22.34 . The trading volume for the day was 1.1 M. The trading history from March 14, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 4.67% . The trading price change against the current closing price is 4.97% . |
Syndax Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Syndax Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Syndax Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Syndax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Syndax Pharmaceuticals Stock history
Syndax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Syndax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Syndax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Syndax Pharmaceuticals stock prices may prove useful in developing a viable investing in Syndax Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 70.4 M | 38.8 M | |
| Net Loss | -134.4 M | -127.7 M |
Syndax Pharmaceuticals Quarterly Net Working Capital |
|
Syndax Pharmaceuticals Stock Technical Analysis
Syndax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Syndax Pharmaceuticals Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Syndax Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Syndax Pharmaceuticals December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Syndax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Syndax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Syndax Pharmaceuticals stock market strength indicators, traders can identify Syndax Pharmaceuticals entry and exit signals to maximize returns
Syndax Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Syndax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Syndax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Syndax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.93) | |||
| Treynor Ratio | (0.70) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.